Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    


Ascension Saint Thomas Opens Cancer Center


 
Tim Adams addresses attendees at the grand opening of the new Saint Thomas Cancer Center on the Midtown campus.

At the end of October, Ascension Saint Thomas Health celebrated the grand opening of their new comprehensive cancer center at Saint Thomas Midtown Hospital. Located on Hayes Street, the Saint Thomas Cancer Center is integrated into the hospital campus.

According to health system officials, the new center was designed to allow patients to access cancer experts and advanced therapies in a supportive and encouraging environment. The space includes most cancer services under one roof, including diagnostics, cancer surgeons, medical oncologists, radiation oncologists, radiologists, and support services.

Citing the array of services under one roof, Ascension Saint Thomas Health President and CEO Tim Adams noted, "The Saint Thomas Cancer Center is the next step in our journey to deliver comprehensive health solutions in convenient, accessible locations."

Fahad Tahir, president and CEO, Ascension Saint Thomas Midtown & West Hospitals, said the center's goal "is to support individuals beyond a disease treatment and to enrich their wellbeing - mind, body, and spirit - led by a sophisticated, skilled clinical team of experts." He added, "We are humbled to expand access to innovative cancer treatments, integrated therapies, comprehensive education and prevention, personalized for those we serve, all under one roof."

The multidisciplinary team is comprised of experts in a range of cancer types, including brain, breast, colon, endocrine, advanced GI, gynecologic, lung and prostate. Certified therapy dogs provide emotional support and companionship to patients and their caregivers. The Saint Thomas Cancer Wellness Studio offers free, restorative programs focused on fitness and movement, nutrition, mindfulness meditation, education, and support during and after treatment.

WEB:

Ascension Saint Thomas Cancer Services

 
Share:

Related Articles:


Recent Articles

Study Finds Certain Genetic Test Not Useful in Predicting Heart Disease Risk

A Polygenic Risk Score -- a genetic assessment that doctors have hoped could predict coronary heart disease (CHD) in patients -- has been found not to be a useful predictive biomarker for disease risk, according to a Vanderbilt study published in the Journal of the American Medical Association.

Read More

Tennessee Infants Exposed to Hep C at Birth Often Not Tested for Virus

Most Tennessee infants exposed to hepatitis C at birth are not later tested to see if they acquired the virus, according to a study by researchers at Monroe Carell Jr. Children's Hospital at Vanderbilt and the Vanderbilt Center for Child Health Policy.

Read More

THA, TMA, TNA Outline Legislative Priorities

With the Tennessee General Assembly back in full swing, the state's major healthcare associations outline 2020 priorities.

Read More

Cardiac Innovation in Nashville

From transplants to trials, Nashville hospitals are leading the way in cardiac care.

Read More

A Modern Love Story: Where Technology, Healthcare & Construction Go Hand-in-Hand

Technology has changed every aspect of our lives. In fact, I had a healthy laugh a few weeks ago when I showed my children an old rotary phone and, get this, they did not know what it was.

Read More

Reeves/Smith Bill to Prevent Next Generation of Nicotine Addiction Garners Broad Industry Support

In late January, a group of more than 25 organizations from across Tennessee announced their support for legislation that seeks to prevent the next generation of nicotine addicts in the state.

Read More

Physician Spotlight: A Heart for Healing

TriStar Summit cardiologist Kristen Kerr is passionate about education, improving outcomes in women's heart health.

Read More

Heart Monitor

Read More

Ifetroban for Treating DMD-Associated Cardiomyopathy

Following successful preclinical trials and FDA funding, Cumberland Pharmaceuticals is preparing to launch a new Phase II trial of ifetroban to treat cardiomyopathy in Duchenne Muscular Dystrophy patients.

Read More

Endocrine Society Celebrates Progress from Bench to Bedside

Endocrine Society Chief Professional & Clinical Affairs Officer Robert Lash, MD, discusses the field, annual meeting, road shows and more.

Read More

Email Print
 
 

 

 


Tags:
Ascension Saint Thomas, Cancer Center, Cancer Wellness Studio, Fahad Tahir, Oncology, Saint Thomas Cancer Center, Saint Thomas Health, Saint Thomas Midtown, Therapy Dogs, Tim Adams
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: